FDA Approved: TOLVAPTAN — Original Application (Endo USA, Inc.)

View source ↗

Summary

FDA approved Endo USA, Inc.'s original application for tolvaptan, a vasopressin V2 receptor antagonist, for the treatment of hyponatremia. This marks the approv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyponatremia
• Syndrome of Inappropriate Antidiuretic Hormone Secretion

Drugs mentioned

• tolvaptan (tolvaptan)

Snippet

ORIG AP for TOLVAPTAN (TOLVAPTAN)